The Latest Advances in Systemic Mastocystosis Molecular Biology Could Change Future Treatment
source: pixabay.com

The Latest Advances in Systemic Mastocystosis Molecular Biology Could Change Future Treatment

By Lauren Thayer from In The Cloud Copy Systemic mastocytosis (SM) is a complicated condition of the blood in which excessive numbers of mast cells (a type of white blood…

Continue Reading The Latest Advances in Systemic Mastocystosis Molecular Biology Could Change Future Treatment
Analyzing the Alzheimer’s Disease Proteome Develops New Drug Targets
source: pixabay.com

Analyzing the Alzheimer’s Disease Proteome Develops New Drug Targets

  As of right now, there are no treatments for Alzheimer's disease, a progressive neurodegenerative disorder. However, that may soon change. A study led by UCLA researchers identified potential drug…

Continue Reading Analyzing the Alzheimer’s Disease Proteome Develops New Drug Targets
RGLS4326 Granted Orphan Drug Designation for Treatment of ADPKD
Photo by Robina Weermeijer on Unsplash

RGLS4326 Granted Orphan Drug Designation for Treatment of ADPKD

  In a recent press release, biopharmaceutical company Regulus Therapeutics, Inc. announced that their drug candidate, RGLS4326, received Orphan Drug Designation for the treatment of autosomal dominant polycystic kidney disease…

Continue Reading RGLS4326 Granted Orphan Drug Designation for Treatment of ADPKD
Three Young People With Chronic Illness Talk About the Challenges They Face
source: pixabay.com

Three Young People With Chronic Illness Talk About the Challenges They Face

  Three people with an eye on the future talk about their innermost feelings and the fact that their lives may be interrupted at any time by their chronic illness.…

Continue Reading Three Young People With Chronic Illness Talk About the Challenges They Face
Combining Three Drugs in the Treatment of Multiple Myeloma Patients Shows Solid Clinical Activity
source: pixabay.com

Combining Three Drugs in the Treatment of Multiple Myeloma Patients Shows Solid Clinical Activity

  According to data from the STOMP trial involving thirty-four patients, a triple regimen has been proven to induce durable responses in pretreated patients with relapsed/refractory multiple myeloma. A recent…

Continue Reading Combining Three Drugs in the Treatment of Multiple Myeloma Patients Shows Solid Clinical Activity
Rare Disease Advocacy Group has Innovative Idea to Raise Awareness Amidst Social Distancing
source: pixabay.com

Rare Disease Advocacy Group has Innovative Idea to Raise Awareness Amidst Social Distancing

Gaucher Disease Awareness Month takes place every October, but amidst this new global pandemic, planning has taken place early to figure out how to make the month as successful as…

Continue Reading Rare Disease Advocacy Group has Innovative Idea to Raise Awareness Amidst Social Distancing
The ADA is 30 Years Old. What Does it Mean to Young People with Disabilities?
source: pixabay.com

The ADA is 30 Years Old. What Does it Mean to Young People with Disabilities?

According to a story from Youth Today, the Americans with Disabilities Act (ADA) was first passed 30 years ago, in 1990. This historic law helps protect people that live with…

Continue Reading The ADA is 30 Years Old. What Does it Mean to Young People with Disabilities?